Published in J Neural Transm (Vienna) on September 27, 2014
Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal (2012) 5.65
Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. J Biol Chem (2002) 4.48
Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging (2001) 3.36
Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch Gen Psychiatry (2004) 2.27
The role of mitochondria in apoptosis. BMB Rep (2008) 1.73
Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders. Int J Neuropsychopharmacol (2010) 1.56
Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. Int J Dev Neurosci (2010) 1.44
Optimization of chemically defined cell culture media--replacing fetal bovine serum in mammalian in vitro methods. Toxicol In Vitro (2010) 1.39
Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder. Arch Gen Psychiatry (2010) 1.36
Proteomic analysis for the assessment of different lots of fetal bovine serum as a raw material for cell culture. Part IV. Application of proteomics to the manufacture of biological drugs. Biotechnol Prog (2006) 1.25
Lithium reduces apoptosis and autophagy after neonatal hypoxia-ischemia. Cell Death Dis (2010) 1.19
Common effects of lithium and valproate on mitochondrial functions: protection against methamphetamine-induced mitochondrial damage. Int J Neuropsychopharmacol (2009) 1.00
Role of glutathione in neuroprotective effects of mood stabilizing drugs lithium and valproate. Neuroscience (2006) 0.99
Oxidative stress in mitochondria: decision to survival and death of neurons in neurodegenerative disorders. Mol Neurobiol (2005) 0.97
Glutathione metabolism and oxidative stress in neurodegeneration Eur J Biochem (2000) 0.95
Rotenone induces apoptosis via activation of bad in human dopaminergic SH-SY5Y cells. J Pharmacol Exp Ther (2004) 0.89
Lithium-induced enhancement of mitochondrial oxidative phosphorylation in human brain tissue. Bipolar Disord (2009) 0.88
Mitochondrial complex I inhibitor rotenone-elicited dopamine redistribution from vesicles to cytosol in human dopaminergic SH-SY5Y cells. J Pharmacol Exp Ther (2007) 0.88
A fresh look at complex I in microarray data: clues to understanding disease-specific mitochondrial alterations in bipolar disorder. Biol Psychiatry (2012) 0.85
Long-term exposure to low lithium concentrations stimulates proliferation, modifies stress protein expression pattern and enhances resistance to oxidative stress in SH-SY5Y cells. Neurochem Res (2008) 0.85
Mitochondrial activity in response to serum starvation in bovine (Bos taurus) cell culture. Cloning Stem Cells (2002) 0.84
Peroxynitrite: a potent oxidizing and nitrating agent. Indian J Exp Biol (2006) 0.83
Decreased global methylation in patients with bipolar disorder who respond to lithium. Int J Neuropsychopharmacol (2013) 0.83
The effect of mood stabilizer lithium on expression and activity of glutathione s-transferase isoenzymes. Neuroscience (2007) 0.83
What is a mood stabilizer? Psychol Med (2006) 0.80
Combined chronic treatment with citalopram and lithium does not modify the regional neurochemistry of nitric oxide in rat brain. J Physiol Pharmacol (2004) 0.80
Inhibition by lithium of the nitrergic relaxation of rat anococcygeus muscle. Nitric Oxide (2008) 0.80
Effect of serum replacement with plysate on cell growth and metabolismin primary cultures of human skeletal muscle. Cytotechnology (2005) 0.79
Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol (2007) 8.10
Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies. Bipolar Disord (2005) 4.94
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord (2009) 3.56
Course of illness, hippocampal function, and hippocampal volume in major depression. Proc Natl Acad Sci U S A (2003) 3.29
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord (2012) 3.01
Longitudinal follow-up of bipolar disorder in women with premenstrual exacerbation: findings from STEP-BD. Am J Psychiatry (2011) 2.06
Bilateral hippocampal volume increase in patients with bipolar disorder and short-term lithium treatment. Neuropsychopharmacology (2007) 2.02
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry (2013) 1.97
Risk and resilience markers in bipolar disorder: brain responses to emotional challenge in bipolar patients and their healthy siblings. Am J Psychiatry (2006) 1.84
Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus. Prog Neuropsychopharmacol Biol Psychiatry (2007) 1.78
Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders. Int J Neuropsychopharmacol (2010) 1.56
Brain structural signature of familial predisposition for bipolar disorder: replicable evidence for involvement of the right inferior frontal gyrus. Biol Psychiatry (2012) 1.47
Oxidative stress markers in bipolar disorder: a meta-analysis. J Affect Disord (2008) 1.46
Impact of comorbid anxiety disorders on outcome in a cohort of patients with bipolar disorder. J Clin Psychiatry (2004) 1.42
Antidepressant treatment-emergent affective switch in bipolar disorder: a prospective case-control study of outcome. Rev Bras Psiquiatr (2006) 1.38
Stress-induced structural remodeling in hippocampus: prevention by lithium treatment. Proc Natl Acad Sci U S A (2004) 1.37
Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci Biobehav Rev (2007) 1.36
Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder. Arch Gen Psychiatry (2010) 1.36
Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects. Neurosci Lett (2007) 1.35
Neuropathologic heterogeneity in HDDD1: a familial frontotemporal lobar degeneration with ubiquitin-positive inclusions and progranulin mutation. Alzheimer Dis Assoc Disord (2007) 1.35
A randomized controlled trial of psychoeducation or cognitive-behavioral therapy in bipolar disorder: a Canadian Network for Mood and Anxiety treatments (CANMAT) study [CME]. J Clin Psychiatry (2012) 1.30
Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder. Int J Neuropsychopharmacol (2008) 1.30
Bilateral hippocampal volume increases after long-term lithium treatment in patients with bipolar disorder: a longitudinal MRI study. Psychopharmacology (Berl) (2007) 1.17
Downregulation in components of the mitochondrial electron transport chain in the postmortem frontal cortex of subjects with bipolar disorder. J Psychiatry Neurosci (2006) 1.17
Subsyndromal symptoms assessed in longitudinal, prospective follow-up of a cohort of patients with bipolar disorder. Bipolar Disord (2003) 1.16
Acute and chronic restraint stress alter the incidence of social conflict in male rats. Horm Behav (2003) 1.16
Treatment-specific changes in decentering following mindfulness-based cognitive therapy versus antidepressant medication or placebo for prevention of depressive relapse. J Consult Clin Psychol (2012) 1.15
The neurobiology of bipolar disorder: focus on signal transduction pathways and the regulation of gene expression. Can J Psychiatry (2002) 1.12
Biomarkers in bipolar disorder: a positional paper from the International Society for Bipolar Disorders Biomarkers Task Force. Aust N Z J Psychiatry (2013) 1.12
Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2008) 1.08
Chronic treatment with mood stabilizers lithium and valproate prevents excitotoxicity by inhibiting oxidative stress in rat cerebral cortical cells. Biol Psychiatry (2005) 1.08
Very low levels of education and cognitive reserve: a clinicopathologic study. Neurology (2013) 1.06
Brain glutamate levels measured by magnetic resonance spectroscopy in patients with bipolar disorder: a meta-analysis. Bipolar Disord (2012) 1.02
Vascular dementia: different forms of vessel disorders contribute to the development of dementia in the elderly brain. Exp Gerontol (2012) 1.01
Lithium response and genetic variation in the CREB family of genes. Am J Med Genet B Neuropsychiatr Genet (2008) 1.01
Traumatic life events in bipolar disorder: impact on BDNF levels and psychopathology. Bipolar Disord (2007) 1.01
Rapid cycling bipolar disorder--diagnostic concepts. Bipolar Disord (2008) 1.00
Suicidal ideation and suicide attempts in bipolar disorder type I: an update for the clinician. Rev Bras Psiquiatr (2009) 1.00
Development and use of a biological rhythm interview. J Affect Disord (2009) 0.99
Glutathione S-transferase is a novel target for mood stabilizing drugs in primary cultured neurons. J Neurochem (2004) 0.99
Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder. Neurosci Lett (2007) 0.98
The International Consortium on Lithium Genetics (ConLiGen): an initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment. Neuropsychobiology (2010) 0.98
Facial emotion recognition in bipolar disorder: a critical review. Rev Bras Psiquiatr (2009) 0.98
3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder. J Psychiatry Neurosci (2009) 0.97
Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia. Bipolar Disord (2009) 0.97
Investigating responders to lithium prophylaxis as a strategy for mapping susceptibility genes for bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry (2005) 0.95
Implication of synapse-related genes in bipolar disorder by linkage and gene expression analyses. Int J Neuropsychopharmacol (2010) 0.95
Proton spectroscopy study of the left dorsolateral prefrontal cortex in pediatric depressed patients. Neurosci Lett (2005) 0.94
Large positive effect of lithium on prefrontal cortex N-acetylaspartate in patients with bipolar disorder: 2-centre study. J Psychiatry Neurosci (2012) 0.93
Desipramine treatment reduces the long-term behavioural and neurochemical sequelae of early-life maternal separation. Int J Neuropsychopharmacol (2003) 0.93
Cognitive function and serum levels of brain-derived neurotrophic factor in patients with bipolar disorder. Bipolar Disord (2009) 0.92
Early intervention in bipolar disorders: clinical, biochemical and neuroimaging imperatives. J Affect Disord (2008) 0.92
Bipolar mixed states: an international society for bipolar disorders task force report of symptom structure, course of illness, and diagnosis. Am J Psychiatry (2013) 0.91
A pilot study of visual backward masking performance among affected versus unaffected offspring of parents with bipolar disorder. Bipolar Disord (2004) 0.91
Chronic administration of ketamine elicits antidepressant-like effects in rats without affecting hippocampal brain-derived neurotrophic factor protein levels. Basic Clin Pharmacol Toxicol (2008) 0.91
Medial temporal lobe abnormalities in pediatric unipolar depression. Neurosci Lett (2007) 0.90
Hippocampal volumes in bipolar disorders: opposing effects of illness burden and lithium treatment. Bipolar Disord (2012) 0.90
Mood stabilizing drug lithium increases expression of endoplasmic reticulum stress proteins in primary cultured rat cerebral cortical cells. Life Sci (2005) 0.90
Prefrontal cortex glutathione S-transferase levels in patients with bipolar disorder, major depression and schizophrenia. Int J Neuropsychopharmacol (2011) 0.90
Bipolar disorder comorbid with alcoholism: a 1H magnetic resonance spectroscopy study. J Psychiatr Res (2009) 0.89
Regulation of ER stress proteins by valproate: therapeutic implications. Bipolar Disord (2002) 0.89
Lower N-acetyl-aspartate levels in prefrontal cortices in pediatric bipolar disorder: a ¹H magnetic resonance spectroscopy study. J Am Acad Child Adolesc Psychiatry (2010) 0.89
Clinical impact of late diagnose of bipolar disorder. J Affect Disord (2005) 0.89
Impact of comorbid migraine on the clinical course of bipolar disorder. Compr Psychiatry (2011) 0.89
A randomized double-blind sham-controlled comparison of unilateral and bilateral repetitive transcranial magnetic stimulation for treatment-resistant major depression. World J Biol Psychiatry (2011) 0.89
Longitudinal outcome in patients with bipolar disorder assessed by life-charting is influenced by DSM-IV personality disorder symptoms. Bipolar Disord (2003) 0.89
Is bipolar disorder a mitochondrial disease? J Psychiatry Neurosci (2007) 0.88
cDNA array reveals differential gene expression following chronic neuroleptic administration: implications of synapsin II in haloperidol treatment. J Neurochem (2002) 0.88
Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in schizophrenia: a study of patients treated with haloperidol or clozapine. Prog Neuropsychopharmacol Biol Psychiatry (2006) 0.87
Morphometric post-mortem studies in bipolar disorder: possible association with oxidative stress and apoptosis. Int J Neuropsychopharmacol (2010) 0.86
Toward clinically applicable biomarkers in bipolar disorder: focus on BDNF, inflammatory markers, and endothelial function. Curr Psychiatry Rep (2013) 0.86
Advances in bipolar disorder: selected sessions from the 2011 International Conference on Bipolar Disorder. Ann N Y Acad Sci (2011) 0.86
Neuroprotective effects of antidepressant and mood stabilizing drugs. J Psychiatry Neurosci (2002) 0.86
A 1HMRS study of the anterior cingulate gyrus in euthymic bipolar patients. Hum Psychopharmacol (2006) 0.85
Cortical inhibitory dysfunction in bipolar disorder: a study using transcranial magnetic stimulation. J Clin Psychopharmacol (2007) 0.85
A fresh look at complex I in microarray data: clues to understanding disease-specific mitochondrial alterations in bipolar disorder. Biol Psychiatry (2012) 0.85
Mismatch between self-reported quality of life and functional assessment in acute mania: a matter of unawareness of illness? J Affect Disord (2007) 0.85
Brain-derived neurotrophic factor serum levels before and after treatment for acute mania. Neurosci Lett (2009) 0.85
[Manic episodes during antidepressant treatment in bipolar disorder]. Rev Bras Psiquiatr (2003) 0.85
Long-acting injectable antipsychotics for the maintenance treatment of bipolar disorder. CNS Drugs (2012) 0.85
Social dysfunction in bipolar disorder: pilot study. Aust N Z J Psychiatry (2008) 0.84
Immunoreactivity of 43 kDa growth-associated protein is decreased in post mortem hippocampus of bipolar disorder and schizophrenia. Neurosci Lett (2006) 0.84
Abnormal resting state corticolimbic blood flow in depressed unmedicated patients with major depression: a (15)O-H(2)O PET study. Hum Brain Mapp (2011) 0.84
Lifetime history of suicide attempts is associated with poorer social skills in patients with bipolar disorder type I. Rev Bras Psiquiatr (2010) 0.84
Effect of abrupt change from standard to low serum levels of lithium: a reanalysis of double-blind lithium maintenance data. Am J Psychiatry (2002) 0.84
Newer antiepileptic drugs in bipolar disorder: rationale for use and role in therapy. CNS Drugs (2002) 0.84
Alterations in phosphorylated cAMP response element-binding protein (pCREB) signaling: an endophenotype of lithium-responsive bipolar disorder? Bipolar Disord (2013) 0.83
Number of manic episodes is associated with elevated DNA oxidation in bipolar I disorder. Int J Neuropsychopharmacol (2013) 0.83
Neuron somal size is decreased in the lateral amygdalar nucleus of subjects with bipolar disorder. J Psychiatry Neurosci (2007) 0.83
Gray matter abnormalities as brain structural vulnerability factors for bipolar disorder: A review of neuroimaging studies of individuals at high genetic risk for bipolar disorder. Aust N Z J Psychiatry (2013) 0.83
Identification of lithium-regulated genes in cultured lymphoblasts of lithium responsive subjects with bipolar disorder. Neuropsychopharmacology (2004) 0.83
A gastrin-releasing peptide receptor antagonist blocks D-amphetamine-induced hyperlocomotion and increases hippocampal NGF and BDNF levels in rats. Peptides (2007) 0.83
Evaluation of genetic damage in a Brazilian population occupationally exposed to pesticides and its correlation with polymorphisms in metabolizing genes. Mutagenesis (2008) 0.82
A novel mutation P112H in the TARDBP gene associated with frontotemporal lobar degeneration without motor neuron disease and abundant neuritic amyloid plaques. Acta Neuropathol Commun (2015) 0.82